| Primary |
| Product Used For Unknown Indication |
25.8% |
| Drug Use For Unknown Indication |
22.7% |
| Dementia Alzheimer's Type |
13.6% |
| Hypertensive Heart Disease |
9.1% |
| Pain |
6.1% |
| Left Ventricular Failure |
4.5% |
| Coronary Artery Disease |
3.0% |
| Hypertension |
3.0% |
| Renal Failure |
3.0% |
| Atrial Fibrillation |
1.5% |
| Depression |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Gout |
1.5% |
| Schizoaffective Disorder |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
|
| Renal Failure Acute |
41.7% |
| Epilepsy |
16.7% |
| Circulatory Collapse |
8.3% |
| Electrocardiogram Qt Prolonged |
8.3% |
| Hypotension |
8.3% |
| Renal Failure |
8.3% |
| Vomiting |
8.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
25.4% |
| Hypertension |
18.6% |
| Hypertensive Heart Disease |
5.9% |
| Pain |
5.9% |
| Product Used For Unknown Indication |
5.5% |
| Chronic Obstructive Pulmonary Disease |
4.6% |
| Glomerulonephritis |
4.6% |
| Immune Thrombocytopenic Purpura |
3.9% |
| Coronary Artery Disease |
3.3% |
| Hiv Infection |
2.9% |
| Left Ventricular Failure |
2.9% |
| Hypercholesterolaemia |
2.6% |
| Type 2 Diabetes Mellitus |
2.6% |
| Cardiomyopathy |
2.0% |
| Oedema |
2.0% |
| Nephrotic Syndrome |
1.6% |
| Renal Transplant |
1.6% |
| Thrombosis Prophylaxis |
1.6% |
| Cardiovascular Disorder |
1.3% |
| Cystitis |
1.3% |
|
| Renal Failure Acute |
21.3% |
| Nephrotic Syndrome |
8.5% |
| Talipes |
8.5% |
| Orthostatic Hypotension |
6.4% |
| Thrombocytopenia |
6.4% |
| Thrombotic Microangiopathy |
6.4% |
| Toxic Epidermal Necrolysis |
6.4% |
| Lung Infiltration |
4.3% |
| Renal Failure |
4.3% |
| Urine Colour Abnormal |
4.3% |
| Vomiting |
4.3% |
| Anaemia |
2.1% |
| Cardiac Failure Acute |
2.1% |
| Coma |
2.1% |
| Death |
2.1% |
| Dizziness |
2.1% |
| Heart Valve Replacement |
2.1% |
| Hyponatraemia |
2.1% |
| Lip And/or Oral Cavity Cancer |
2.1% |
| Multi-organ Failure |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.2% |
| Drug Use For Unknown Indication |
15.2% |
| Hypertension |
11.4% |
| Pain |
4.3% |
| Prophylaxis |
3.8% |
| Atrial Fibrillation |
3.2% |
| Cardiac Failure |
2.6% |
| Nausea |
2.5% |
| Rheumatoid Arthritis |
2.4% |
| Diabetes Mellitus |
2.1% |
| Non-small Cell Lung Cancer |
2.1% |
| Coronary Artery Disease |
2.0% |
| Hyperparathyroidism Secondary |
2.0% |
| Myocardial Ischaemia |
2.0% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Prostate Cancer |
1.7% |
| Type 2 Diabetes Mellitus |
1.6% |
| Breast Cancer |
1.5% |
| Renal Transplant |
1.5% |
| Pyrexia |
1.4% |
|
| Urinary Retention |
9.4% |
| Renal Failure |
7.9% |
| Renal Failure Acute |
7.9% |
| Death |
6.9% |
| Urinary Tract Infection |
6.4% |
| Sepsis |
5.4% |
| Renal Impairment |
5.0% |
| Hypophosphataemia |
4.5% |
| Toxic Epidermal Necrolysis |
4.5% |
| Ventricular Fibrillation |
4.5% |
| Dyspnoea |
4.0% |
| Narcotic Intoxication |
4.0% |
| Sick Sinus Syndrome |
4.0% |
| Vomiting |
4.0% |
| Weight Decreased |
4.0% |
| Weight Increased |
4.0% |
| Cardiac Failure |
3.5% |
| Pancytopenia |
3.5% |
| Pulmonary Hypertension |
3.5% |
| Syncope |
3.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
67.4% |
| Product Used For Unknown Indication |
19.6% |
| Mania |
4.3% |
| Schizoaffective Disorder |
4.3% |
| Hypertension |
2.2% |
| Type 2 Diabetes Mellitus |
2.2% |
|
| Electrocardiogram Qt Prolonged |
33.3% |
| Hypoglycaemia |
16.7% |
| Renal Failure |
16.7% |
| Right Atrial Dilatation |
16.7% |
| Therapeutic Agent Toxicity |
16.7% |
|
